Delivery Order SPE2DB22D3301-SPE2DB25FZ0WT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,675.22 to AmerisourceBergen Drug Corp for the supply of Loestrin FE 1-20 tablets in 28-count packages. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of July 30, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $2,838.58 to AmerisourceBergen Drug Corp for Loestrin 21 1-20 Tablet (21-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award, which received no set-aside designation, represents a firm fixed-price delivery order to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $6,576.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Loestrin FE 1-20 tablets (28-count packaging) on September 11, 2025, with completion targeted for September 12, 2025. This non-competitive delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The performance...
- The Defense Logistics Agency awarded a $3,400.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LOESTRIN FE 1-20 tablets (28-count packaging) on August 21, 2025, with an ultimate completion date of August 22, 2025. This is a non-set-aside, competitively awarded contract executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $5,733.50 to AmerisourceBergen Drug Corp for Loestrin FE 1.5-30 tablets (28-count units) with a firm fixed price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $6,208.22 to AmerisourceBergen Drug Corp for Loestrin FE 1-20 tablets on July 30, 2025, with performance completion by July 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be supplied to support federal medical procurement needs, with performance occurring at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,247.15 on July 21, 2025, for the supply of Lo Loestrin FE 1-10 tablets in 28-count packages. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office....
- The Defense Logistics Agency awarded a delivery order valued at $11,160.66 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packages) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,102.40 to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 tablets (28-count packaging) on July 21, 2025, with completion expected by July 22, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location at...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ0WTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,131.85 to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Loestrin FE 1-20 tablets in 28-count packages. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award of this pharmaceutical product. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania headquarters, with an ultimate completion date of September 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical prime vendor agreement extending through December 2026 that enables the company to supply medications, vaccines, and medical supplies globally to support military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of pharmaceutical deliveries under its DLA contract vehicle, encompassing brand-name and generic medications across multiple therapeutic domains. This specific order for Loestrin FE represents a routine delivery against the broader pharmaceutical supply agreement that enables military and federal healthcare systems to maintain consistent access to essential medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/12/25 |